End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.16 CNY | -1.46% | -10.19% | -36.40% |
Mar. 06 | Menovo Pharma's Unit Gets Nod to Market Clopidogrel Hydrogen Sulfate Tablets | MT |
Mar. 04 | Menovo Pharma Gets Nod to Market Raw Drug Ingredient for Hypertension Into EU Market; Shares Up 3% | MT |
Sales 2023 * | 1.5B 206M | Sales 2024 * | 1.75B 241M | Capitalization | 2.59B 358M |
---|---|---|---|---|---|
Net income 2023 * | 120M 16.58M | Net income 2024 * | 229M 31.63M | EV / Sales 2023 * | 1.74 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.49 x |
P/E ratio 2023 * |
21.7
x | P/E ratio 2024 * |
11.4
x | Employees | 2,297 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 68.38% |
1 day | -1.46% | ||
1 week | -10.19% | ||
Current month | -13.27% | ||
1 month | -16.14% | ||
3 months | -25.85% | ||
6 months | -37.96% | ||
Current year | -36.40% |
Managers | Title | Age | Since |
---|---|---|---|
Cheng Zhi Yao
CEO | Chief Executive Officer | 49 | 04-02-18 |
Gao Feng Ying
DFI | Director of Finance/CFO | 53 | 19-10-11 |
Xiao Qing Zhang
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Xin Min Bao
BRD | Director/Board Member | 54 | 18-06-19 |
Cheng Zhi Yao
CEO | Chief Executive Officer | 49 | 04-02-18 |
Zhi Yan Fan
PRN | Corporate Officer/Principal | 41 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 12.16 | -1.46% | 2,363,270 |
24-04-18 | 12.34 | -1.59% | 2,691,726 |
24-04-17 | 12.54 | +3.64% | 2,791,553 |
24-04-16 | 12.1 | -6.13% | 4,307,715 |
24-04-15 | 12.89 | -4.80% | 4,426,955 |
End-of-day quote Shanghai S.E., April 18, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.40% | 364M | |
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |
- Stock Market
- Equities
- 603538 Stock